These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29392371)

  • 41. Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.
    Nijs M; Wajs E; Aluisio L; Turkoz I; Daly E; Janik A; Borentain S; Singh JB; DiBernardo A; Wiegand F
    Int J Neuropsychopharmacol; 2020 Jul; 23(7):426-433. PubMed ID: 32270176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis.
    Papakostas GI; Salloum NC; Hock RS; Jha MK; Murrough JW; Mathew SJ; Iosifescu DV; Fava M
    J Clin Psychiatry; 2020 May; 81(4):. PubMed ID: 32459407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Esketamine Added to Propofol Sedation on Desaturation and Hypotension in Bidirectional Endoscopy: A Randomized Clinical Trial.
    Song N; Yang Y; Zheng Z; Shi WC; Tan AP; Shan XS; Liu H; Meng L; Peng K; Ji FH
    JAMA Netw Open; 2023 Dec; 6(12):e2347886. PubMed ID: 38117498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
    Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
    Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
    Craft S; Raman R; Chow TW; Rafii MS; Sun CK; Rissman RA; Donohue MC; Brewer JB; Jenkins C; Harless K; Gessert D; Aisen PS
    JAMA Neurol; 2020 Sep; 77(9):1099-1109. PubMed ID: 32568367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Switching to Intranasal Esketamine Maintains the Antidepressant Response to Intravenous Racemic Ketamine Administration: A Case Series of 10 Patients.
    Banov MD; Landrum RE; Moore MB; Szabo ST
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):594-599. PubMed ID: 34411009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder.
    Jucaite A; Öhd J; Potter AS; Jaeger J; Karlsson P; Hannesdottir K; Boström E; Newhouse PA; Paulsson B
    Psychopharmacology (Berl); 2014 Mar; 231(6):1251-65. PubMed ID: 23640072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers.
    Wesnes KA; Garratt C; Wickens M; Gudgeon A; Oliver S
    Br J Clin Pharmacol; 2000 Feb; 49(2):110-7. PubMed ID: 10671904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential role of nitric oxide in the psychedelic symptoms induced by racemic ketamine and esketamine in human volunteers.
    Jonkman K; van der Schrier R; van Velzen M; Aarts L; Olofsen E; Sarton E; Niesters M; Dahan A
    Br J Anaesth; 2018 May; 120(5):1009-1018. PubMed ID: 29661378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Low Dose of Ketamine on Learning Memory Function in Patients Undergoing Electroconvulsive Therapy-A Randomized, Double-Blind, Controlled Clinical Study.
    Chen Q; Min S; Hao X; Peng L; Meng H; Luo Q; Chen J; Li X
    J ECT; 2017 Jun; 33(2):89-95. PubMed ID: 27828927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design.
    Wigal T; Brams M; Frick G; Yan B; Madhoo M
    Postgrad Med; 2018 Jun; 130(5):481-493. PubMed ID: 29809075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects.
    Sethna NF; Liu M; Gracely R; Bennett GJ; Max MB
    Anesth Analg; 1998 Jun; 86(6):1250-6. PubMed ID: 9620514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prehospital Analgesia With Intranasal Ketamine (PAIN-K): A Randomized Double-Blind Trial in Adults.
    Andolfatto G; Innes K; Dick W; Jenneson S; Willman E; Stenstrom R; Zed PJ; Benoit G
    Ann Emerg Med; 2019 Aug; 74(2):241-250. PubMed ID: 30926189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial.
    Pickering G; Pereira B; Morel V; Corriger A; Giron F; Marcaillou F; Bidar-Beauvallot A; Chandeze E; Lambert C; Bernard L; Delage N
    Anesthesiology; 2020 Jul; 133(1):154-164. PubMed ID: 32384291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis.
    Hock RS; Feeney A; Iovieno N; Murrough JW; Mathew SJ; Iosifescu DV; Fava M; Jha MK; Papakostas GI
    J Clin Psychiatry; 2022 Dec; 84(1):. PubMed ID: 36516320
    [No Abstract]   [Full Text] [Related]  

  • 56. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials.
    Saad Z; Hibar D; Fedgchin M; Popova V; Furey ML; Singh JB; Kolb H; Drevets WC; Chen G
    Int J Neuropsychopharmacol; 2020 Dec; 23(9):549-558. PubMed ID: 32367114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
    Peyro Saint Paul L; Creveuil C; Heinzlef O; De Seze J; Vermersch P; Castelnovo G; Cabre P; Debouverie M; Brochet B; Dupuy B; Lebiez P; Sartori É; Clavelou P; Brassat D; Lebrun-Frenay C; Daplaud D; Pelletier J; Coman I; Hautecoeur P; Tourbah A; Defer G
    J Neurol Sci; 2016 Apr; 363():69-76. PubMed ID: 27000224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ketamine and other glutamate receptor modulators for depression in adults.
    Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis.
    Terao I; Tsuge T; Endo K; Kodama W
    J Affect Disord; 2024 Feb; 346():49-56. PubMed ID: 37949235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.